HoffmanEP, BrownRHJr, KunkelLM. Dystrophin: the protein product of Duchenne muscular dystrophy locus. Cell51: 919–928, 1987.
2.
PetrofBJ. The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem179: 111–123, 1998.
3.
BogdanovichS, PerkinsKJ, KragTOB, KhuranaTS. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J Mol Med82: 102–115, 2004.
4.
ChenYW, ZhaoP, BorupR, HoffmanEP. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol151: 1321–1336, 2000.
5.
ThatchenkoAV, Le CamG, LégerJJ, DeschesneCA. Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse. Biochim Biophys Acta1500: 17–30, 2000.
6.
ThatchenkoAV, PiétuG, CrosN, Gannoun-ZakiL, AuffrayC, LégerJJ, DeschesneCA. Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients. Neuromuscul Disord11: 269–277, 2001.
7.
LangenbachKJ, RandoTA. Inhibition of dystroglycan binding to laminin disrupts the P13K/AKT pathway and survival signaling in muscle cells. Muscle Nerve26: 644–653, 2002.
8.
LangJM, EsserKA, DuPont-VersteegdenEE. Altered activity of signaling pathways in diaphragm and tibialis anterior muscle of dystrophic mice. Exp Biol Med229: 503–511, 2004.
